Since the endocrine resistance becomes the major challenge for breast cancer patients, the understanding of ERα signaling activity, including ERα expression and stability regulation, is important in the development of novel anti-estrogen therapy and overcome endocrine resistance. This evidence concerns the gene ESR1 and breast carcinoma.